Capricor Therapeutics Inc Cash Flow Reinvestment Rate
Capricor Therapeutics Inc cash flow reinvestment rate. Capricor Therapeutics Inc (CAPR) has a Cash Flow Reinvestment Rate of 0.76x as of March 2023, reinvesting $3.21 Million (capex $453.12K plus investments $-2.76 Million) from operating cash flow of $4.21 Million. Explore Capricor Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Capricor Therapeutics Inc (2014–2022)
Cash flow reinvestment rate of Capricor Therapeutics Inc from 2014 to 2022. Historical reinvestment intensity for Capricor Therapeutics Inc across 2 annual periods. Explore Capricor Therapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Capricor Therapeutics Inc Cash Flow Reinvestment Rate by Year (2014–2022)
Capricor Therapeutics Inc cash flow reinvestment rate by year from 2014 to 2022. Year-by-year capital reinvestment analysis for Capricor Therapeutics Inc. For the full cash flow conversion analysis, see Capricor Therapeutics Inc operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 7.13x | $35.07 Million | $4.92 Million | $3.36 Million | ▲ +1230.6% |
| 2014 | 0.54x | $513.90K | $958.56K | $186.43K | — |